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Focus on . . . LKB1/AMPK signalingFocus on LKB1/AMPK signaling is the ﬁrst of a series of reviews
dedicated to the topic of tumor suppression and the speciﬁc func-
tion of proteins involved. In this series FEBS Letters aims to provide
a most comprehensive survey of the important and extremely
complex area of cancer progression and the regulatory functions
tumor suppressor (TS) proteins exert.
Since the discovery of the ﬁrst TS, the Retinoblastoma protein,
whose best-known activity is to repress E2F-regulated genes by
recruiting regulatory activities to E2F-regulated promoters (for a
recent review see [1]), many other TSs have been discovered,
including adenomatous polyposis coli (APC) protein, BRCA1/2, de-
leted in colon carcinoma (DCC), neuroﬁbromatosis type 1 (NF1),
p53, TSC1/TSC2, Wilms tumor 1 (WT1) and the ‘‘suppression of
tumorigenicity’’ (ST) proteins, all of which promote cancer progres-
sion or metastasis via mutagenesis [2,3]. TS proteins act at differ-
ent levels along tumorigenesis pathways regulating diverse
cellular activities, such as detection and repair of DNA damage, cell
cycle checkpoint responses, protein ubiquitination and degrada-
tion, mitogenic signaling, cell differentiation and migration and
tumor angiogenesis.
Liver kinase B1 (LKB1) is a TS protein that impacts a wide range
of cellular processes, including cell cycle arrest, p53-mediated
apoptosis, Wnt signaling, TGF-b signaling, ras-induced cell trans-
formation and energy metabolism [4]. To mediate all these activi-
ties, LKB1 is activated in a trimeric complex with STE20-related
adaptor (STRAD) and MO25 triggering at least 14 different kinase
activities. Vaahtomeri and Mäkelä [5] provide a detailed overview
on the molecular mechanisms of LKB1, Alexander and Walker are
reviewing the implication of LKB1-AMPK signaling in response to
stress and damage [6] and Shorning and Clarke [7] summarize data
on LKB1 functions in vivo and the consequences of its loss. Phos-
phorylation of the AMP-activated kinase (AMPK) by LKB1 is in-
volved in the regulation of cellular metabolism, as reviewed by
Mantovani and Roy [8], and is a necessary step in regulating cell
growth by the mTOR pathway, as referred to by Han and Sahin
[9] pointing to the multi-faceted roles of TSC1/TSC2 signaling in
the central nervous system. In addition, this phosphorylation con-
verts energy-sensing information into the activation of Myosin II to
maintain epithelial cell architecture and to complete cell division
(Mirouse and Billaud [10]). Finally, Wang et al. [11] discuss
cross-talks between AMPK and silent information regulator T10014-5793/$36.00  2011 Federation of European Biochemical Societies. Published by E
doi:10.1016/j.febslet.2011.03.011(SIRT1) as a stress and energy sensor suggested to control the
senescence program in mammalian cells.
Although LKB1 was initially discovered because of its role as a
TS, it is still not clear which pathways are involved in tumor sup-
pression. Thus, identiﬁcation of the downstream targets implicated
in tumor initiation and metastasis appears to be an urgent chal-
lenge. In addition, besides the role LKB1 plays in tumor suppres-
sion, the involvement of LKB1 in a wide variety of cellular
activities promises highly interesting insights to be revealed by
future studies in this research area.
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